Blends & StacksUpdated July 25, 2026 · Educational reference

KLOW Blend: GHK-Cu + TB-500 + BPC-157 + KPV Explained

Also known as: KLOW (GHK-Cu + TB-500 + BPC-157 + KPV) · KLOW blend · KL80 · GHK-Cu + TB-500 + BPC-157 + KPV

ClassPre-mixed blend — four repair / anti-inflammatory peptides
ComponentsGHK-Cu + TB-500 + BPC-157 + KPV
Typical doseCommonly sold as an ~80 mg total-peptide vial; ratios vary
Half-lifeDiffers per component
Typical routeSubQ
Combination evidenceNone. Four compounds, no combination study, no standard formulation
Quick answer

KLOW is GLOW plus KPV — the same GHK-Cu, TB-500 and BPC-157 base with a fourth peptide added. KPV is a tripeptide fragment of alpha-MSH studied preclinically for anti-inflammatory activity, particularly in gut inflammation models, and its inclusion is meant to add an anti-inflammatory arm to a repair blend. Commonly sold as an ~80 mg total-peptide vial, sometimes labelled KL80. It is the most complex blend in common circulation, and complexity here means less control and more variance between sellers rather than more effect. Educational only, not medical advice.

What KPV adds

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone — three amino acids, lysine-proline-valine — that appears to retain the parent hormone's anti-inflammatory activity without its pigmentary effects. Most of the work on it is preclinical, with the strongest signal in models of intestinal inflammation, and it is often discussed for gut and skin inflammation on that basis.

The logic of adding it to a repair blend is that inflammation modulation sits alongside tissue repair rather than duplicating it. As with the other three, that is a mechanistic argument, not a demonstrated result in people.

Four compounds, one fixed ratio

Every additional component in a blend removes a degree of freedom. With four peptides in one vial you cannot change one dose without changing all four, and you cannot attribute an effect — good or bad — to any single one of them.

That last point is the practical cost. If something works, you do not know which part. If you react badly, you do not know what to drop. For a category with no human efficacy data to lean on, self-experimentation is the only feedback available, and a four-way blend is close to the worst possible design for learning anything from it.

Vials are commonly around 80 mg total — the "KL80" label refers to this — but ratios are not standardised.

The honest read

Four peptides, none with human efficacy trials for the injected use being sold, in an unstandardised ratio, with no study of any two of them together let alone all four.

GHK-Cu's real evidence remains topical. KPV's remains preclinical. BPC-157 and TB-500 remain animal-model compounds. None of that makes the blend useless — it means nobody, including the people selling it, knows what it does in humans.

How to track KLOW in Stackeddd

If you run a four-way blend, record the exact ratio from the vial and change nothing else at the same time. It is the only way to get any signal at all out of a product designed to make attribution impossible.

Model it yourself · free, no account

Reconstitution Calculator

A blend is one reconstitution that sets the dose of every compound in the vial — get the water volume right once and every draw after it is correct.

Related compounds

Related reading: What peptides can you mix in the same syringe? · Peptide reconstitution math: how much BAC water to add

Frequently asked questions

What is in KLOW?

GHK-Cu, TB-500, BPC-157 and KPV in a single vial, commonly around 80 mg of total peptide — sometimes labelled KL80. It is GLOW with KPV added as a fourth component. Ratios are not standardised between sellers.

What does KPV do?

KPV is a three-amino-acid fragment of alpha-MSH that appears to keep the parent hormone's anti-inflammatory activity without its pigmentary effects. The research is largely preclinical, with the clearest signal in intestinal-inflammation models.

Is a four-peptide blend better than a simpler one?

It is harder to learn anything from. A fixed four-way ratio means you cannot adjust one component, cannot attribute a benefit to any single part, and cannot tell what to drop if you react badly. In a category with no human efficacy data, that makes it a poor design for self-experimentation.

This is educational information, not medical advice. Doses and protocols above reflect published references and community practice — protocol decisions belong with your prescribing physician. Generic names used throughout. How this reference is built & how the AI is tested →

STACKEDDD

Track it instead of guessing.

Doses, reconstitution, bloodwork, and an AI coach grounded in your own data — free to start, on the App Store and Google Play.

App StoreGoogle Play

← Back to the compound library